B-cell targeted therapy in systemic lupus erythematosus: potential of rituximab

被引:3
作者
Wiesik-Szewczyk, E. [1 ]
Olesinska, M. [1 ]
机构
[1] Inst Rheumatol, Dept Connect Tissue Dis, PL-02637 Warsaw, Poland
关键词
B cells; systemic lupus erythematosus; rituximab; off-label use; clinical trials;
D O I
10.2147/BTT.S25407
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Systemic lupus erythematosus (SLE) is a complex autoimmune disease of unknown etiology, and the limited available therapeutic options for this disease, are frustrating to both clinicians and patients. However, recent advances in the understanding of disease mechanisms have given rise to numerous studies on specific approaches to SLE treatment. Rituximab, the first chimeric, mouse-human monoclonal antibody which is directed against CD20, seems to be a new therapeutic option. The purpose of this review is to explain the current clinical evidence on the therapeutic use of rituximab in adult SLE patients. Two randomized clinical trials with rituximab (the EXPLORER and LUNAR studies) failed to prove efficacy of this drug on SLE. Ongoing data analysis continues to explain the reasons behind why this treatment fails to work. However data from open source and observational studies contrast with clinical trials results. The global analysis of this data supports the off-label use of rituximab in subsets of SLE that are refractory to standard treatment.
引用
收藏
页码:347 / 354
页数:8
相关论文
共 53 条
[1]   Variability in the biological response to anti-CD20 B cell depletion in systemic lupus erythaematosus [J].
Albert, D. ;
Dunham, J. ;
Khan, S. ;
Stansberry, J. ;
Kolasinski, S. ;
Tsai, D. ;
Pullman-Mooar, S. ;
Barnack, F. ;
Striebich, C. ;
Looney, R. J. ;
Prak, E. T. Luning ;
Kimberly, R. ;
Zhang, Y. ;
Eisenberg, R. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) :1724-1731
[2]  
Anolik JH, 2007, BULL HOSP JT DIS, V65, P182
[3]   Delayed memory B cell recovery in peripheral blood and lymphoid tissue in systemic lupus erythematosus after B cell depletion therapy [J].
Anolik, Jennifer H. ;
Barnard, Jennifer ;
Owen, Teresa ;
Zheng, Bo ;
Kemshetti, Sunil ;
Looney, R. John ;
Sanz, Inaki .
ARTHRITIS AND RHEUMATISM, 2007, 56 (09) :3044-3056
[4]   Rituximab improves peripheral B cell abnormalities in human systemic lupus erythematosus [J].
Anolik, JH ;
Barnard, J ;
Cappione, A ;
Pugh-Bernard, AE ;
Felgar, RE ;
Looney, RJ ;
Sanz, I .
ARTHRITIS AND RHEUMATISM, 2004, 50 (11) :3580-3590
[5]   Cutting Edge: The PTPN22 Allelic Variant Associated with Autoimmunity Impairs B Cell Signaling [J].
Arechiga, Adrian F. ;
Habib, Tania ;
He, Yantao ;
Zhang, Xian ;
Zhang, Zhong-Yin ;
Funk, Andrew ;
Buckner, Jane H. .
JOURNAL OF IMMUNOLOGY, 2009, 182 (06) :3343-3347
[6]   Rituximab and mycophenolate mofetil for relapsing proliferative lupus nephritis: a long-term prospective study [J].
Boletis, John N. ;
Marinaki, Smaragde ;
Skalioti, Chryssanthe ;
Lionaki, Sofia S. ;
Iniotaki, Aliki ;
Sfikakis, Petros P. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (07) :2157-2160
[7]   Clinical trials in lupus: what have we learned so far? Understanding the gap between reality and expectation [J].
Bruce, Ian N. ;
Gordon, Caroline ;
Merrill, Joan T. ;
Isenberg, David .
RHEUMATOLOGY, 2010, 49 (06) :1025-1027
[8]   B cell depletion therapy in systemic lupus erythaematosus: relationships among serum B lymphocyte stimulator levels, autoantibody profile and clinical response [J].
Cambridge, G. ;
Isenberg, D. A. ;
Edwards, J. C. W. ;
Leandro, M. J. ;
Migone, T-S ;
Teodorescu, M. ;
Stohl, W. .
ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (07) :1011-1016
[9]   Long-term efficacy and safety of rituximab in refractory and relapsing systemic lupus erythematosus [J].
Catapano, Fausta ;
Chaudhry, Afzal N. ;
Jones, Rachel B. ;
Smith, Kenneth G. C. ;
Jayne, David W. .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (11) :3586-3592
[10]   Rituximab treatment of systemic lupus erythematosus in controlled trials and in clinical practice: Two sides of the same coin [J].
Conti, Fabrizio ;
Perricone, Carlo ;
Ceccarelli, Fulvia ;
Valesini, Guido .
AUTOIMMUNITY REVIEWS, 2010, 9 (11) :716-720